AstraZeneca–BMS merger talks continue…combined market cap near $400B

1. 1Reports say merger talks between AstraZeneca (AZN) and Bristol-Myers Squibb (BMY) are still ongoing
2. 2If completed, the combined company would become the world's fourth-largest pharma with a market cap of roughly $400B, and a stock-and-cash deal is expected
3. 3Commitments to U.S. investment, R&D, production, and jobs are required, and a potential full re-listing in New York has also been discussed

Source Barrons.com +3 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →